Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-15

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate the safety, efficacy and patient satisfaction with the ReX Remote Digital Nurse by patients receiving solid oral medication.

The study will evaluate and monitor use of ReX in respect of:

* treatment duration
* adverse events
* patient adherence and compliance
* engagement with ReX via patient-reported outcomes

Patients participating in the study will receive their normal medication as standard of care via ReX. Progress will be monitored via patients' responses to questions presented on the ReX touch screen.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics

NCT04091711

Oncology Adherence, Medication Side Effect

SUSPENDED NA

Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma

NCT03229083

Advanced Renal Cell Carcinoma

COMPLETED NA

Optimizing the Management of Patients With Oral Therapy

NCT03623490

Kidney Cancer Breast Cancer

TERMINATED NA

Collaborative Network to Take Responsibility for Oral Anticancer Therapy

NCT02861209

Breast Cancer ALL Lung Cancer +3 more

UNKNOWN NA

Observational Study to Assess Adherence Oral Anticancer Therapies

NCT03195972

Adherence, Patient

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ReX platform is a class 1 FDA device listed under product code NXB Dispenser Solid Medication. It comprises:

* Hand-held medication dispenser with touch screen (ReX Remote Digital Nurse).
* Disposable cartridge pre-loaded with pills or capsules. The cartridge includes an integral mouthpiece. Patients inhale at the mouthpiece causing pills to be dispensed into the mouth.
* Web application (ReX Treatment Manager) which collects data generated by the ReX hand-held dispenser.

ReX manages and monitors medication-based therapy by means of:

* Reminders to take pills. Reminders are sent to patients and caregivers by email, SMS or via the telephone support team.
* Electronic patient recorded outcomes (ePROs) presented to patients via the dispenser touch screen. ePROs include questions, tips and reminders.
* Notifications sent by email or SMS in the event of the patient exceeding a pre-defined threshold.

In this study, following training, patients will be offered their standard oral medication via the ReX Remote Digital Nurse. They will receive cartridges pre-loaded with medication by the pharmacy. Safety, efficacy and patient satisfaction with the device are monitored over a 24-week period by phone calls and periodic questionnaires.

Data collected by the ReX Remote Digital Nurse include:

* medication name
* prescribed dosage
* doses taken per day
* pills taken per dose
* ePRO responses
* missed pill intakes

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Any Solid Oral Medication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving solid oral medication as a standard of care.

Solid oral medication administered via the ReX Remote Digital Nurse.

Use of ReX to dispense and monitor solid oral medication therapy.

Intervention Type DEVICE

ReX Remote Digital Nurse comprising hand-held dispenser, disposable drug cartridge and web application (ReX Treatment Manager).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Use of ReX to dispense and monitor solid oral medication therapy.

ReX Remote Digital Nurse comprising hand-held dispenser, disposable drug cartridge and web application (ReX Treatment Manager).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18 years of age or older.
2. Care team recommends the use of ReX as a standard of care.
3. Patients have 5th grade reading level.
4. Patient was prescribed oral medication.
5. Patient takes medication at home.

Exclusion Criteria

1. Patient has significant physical disability including poor fine motor skills, impaired visual or auditory faculties, mental disorders or other impairment affecting ability to provide Informed Consent or use the ReX dispensing unit effectively.
2. Patient failed to pass the learning module during ReX onboarding flow.
3. Patient is at end stage or terminal illness with anticipated life expectancy of 6 months or less.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No